Pancreatic mucinous cystadenocarcinoma

Summary

Pancreatic mucinous cystadenocarcinoma (MONDO:0004156) is a disease. A subtype of pancreatic cystadenocarcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	pancreatic mucinous cystadenocarcinoma
Mondo ID	MONDO:0004156
DOID	DOID:7234
NCIT	C5713
UMLS	C2063873
MedGen	1433902
GARD	0027663
Anatomy (UBERON)	UBERON:0001264
Is cancer (heuristic)	no

Also known as: colloid Cystadencarcinoma of pancreas · colloid Cystadencarcinoma of the pancreas · colloidal Cystadencarcinoma of pancreas · colloidal Cystadencarcinoma of the pancreas · mucinous Cystadencarcinoma of pancreas · mucinous Cystadencarcinoma of the pancreas · pancreatic colloid Cystadencarcinoma · pancreatic colloidal Cystadencarcinoma

Disease family

This is a subtype of pancreatic cystadenocarcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › adenocarcinoma › cystadenocarcinoma › pancreatic cystadenocarcinoma › pancreatic mucinous cystadenocarcinoma

Related subtypes (2): pancreatic serous cystadenocarcinoma, pancreatic acinar cell cystadenocarcinoma

Subtypes (2): pancreatic mucinous-cystic neoplasm with an associated invasive carcinoma, pancreatic non-invasive mucinous cystadenocarcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.